Evidence map›Paper›PMID 42904855›Full record

ReviewChemistry & biodiversity2026

Botanical, Phytochemistry, Pharmacology and Applications of Genus Heracleum: A Review.

Nan Zhang, Yuan Li, Zhi-Yuan Guo, Ye-Zi Ma, Miao-Miao Xu, Dong-Dong Zhang

Abstract readReview
In one paragraph

Review in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nan ZhangXi' an Institute for Food and Drug Control, Xi' an, Shaanxi, People's Republic of China.
Yuan LiXi' an Institute for Food and Drug Control, Xi' an, Shaanxi, People's Republic of China.
Zhi-Yuan GuoXi' an Institute for Food and Drug Control, Xi' an, Shaanxi, People's Republic of China.
Ye-Zi MaSchool of Pharmacy, Shaanxi University of Chinese Medicine, Shaanxi Key Laboratory of Research and Application of "Taibai Qi Yao, Xianyang, People's Republic of China.ORCID https://orcid.org/0009-0009-6279-5869
Miao-Miao XuXi' an Institute for Food and Drug Control, Xi' an, Shaanxi, People's Republic of China.
Dong-Dong ZhangSchool of Pharmacy, Shaanxi University of Chinese Medicine, Shaanxi Key Laboratory of Research and Application of "Taibai Qi Yao, Xianyang, People's Republic of China.ORCID https://orcid.org/0000-0003-0956-1261

Funding

Discovery and Application of Efficacy Substances in TaibaiQi MedicinesInnovation Team Project of Shaanxi University of Chinese Medicine 2023-CXTD-05Key Discipline Project of the National Administration of Traditional Chinese Medicine zyyzdxk-2023202the Qinchuangyuan Traditional Chinese Medicine Industry Innovation Hub Project L2024-QCY-ZYYJJQ-X32Youth Innovation Team of Shaanxi Provincial Department of Education
6 · The paper itself

Abstract

The genus Heracleum belongs to the Apiaceae family and is widely distributed across the Northern Hemisphere, predominantly in Eurasia, with approximately 70 species recorded globally. This genus possesses abundant medicinal resources and has a long history of use in traditional medicine, commonly employed to treat various conditions such as inflammation, gastrointestinal bloating, and stomach pain. In recent years, researchers worldwide have isolated and identified numerous chemical constituents from this genus, with coumarin derivatives emerging as the primary bioactive compounds. These exhibit diverse pharmacological activities, including anti-inflammatory, antitumor, hypoglycemic, hepatoprotective, neuroprotective, and antioxidant effects. Moreover, the novel and complex coumarin oligomers (dimers to tetramers) such as canditririn A (trimer) and canditetrarin B (tetramer) with unique cage-like structures present in these plants hold significant promise for medicinal development. This review systematically summarizes the botanical characteristics, chemical constituents, pharmacological activities, and applications of Heracleum species, aiming to provide references for further exploration of their therapeutic value and research development.

Indexed as

Anti-Inflammatory AgentsAntineoplastic Agents, PhytogenicAntioxidantsHeracleumHypoglycemic AgentsPhytochemicalsAnimalsCoumarinsHumansNeuroprotective AgentsAnti-Inflammatory AgentsAntineoplastic Agents, PhytogenicAntioxidantsCoumarinsHypoglycemic AgentsNeuroprotective AgentsPhytochemicalsanti‐inflammatoryantitumorapplicationscoumarinHeracleum

Identifiers

PMID42904855
PMCPMC13685480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.